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Raccoon dog is one of the suspected intermediate hosts of severe acute respiratory syndrome
coronavirus (SARS-CoV). In this study, the angiotensin-converting enzyme 2 (ACE2) gene of
raccoon dog (rdACE2) was cloned and sequenced. The amino acid sequence of rdACE2 has
identities of 99.3, 89.2, 83.9 and 80.4% to ACE2 proteins from dog, masked palm civet
(pcACE2), human (huACE2) and bat, respectively. There are six amino acid changes in rdACE2
compared with huACE2, and four changes compared with pcACE2, within the 18 residues of
ACE2 known to make direct contact with the SARS-CoV S protein. A HeLa cell line stably
expressing rdACE2 was established; Western blot analyses and an enzyme-activity assay
indicated that the cell line expressed ACE2 at a similar level to two previously established cell
lines that express ACE2 from human and masked palm civet, respectively. Human
immunodeficiency virus-backboned pseudoviruses expressing spike proteins derived from human
SARS-CoV or SARS-CoV-like viruses of masked palm civets and raccoon dogs were tested for
their entry efficiency into these cell lines. The results showed that rdACE2 is a more efficient
receptor for human SARS-CoV, but not for SARS-CoV-like viruses of masked palm civets and
raccoon dogs, than huACE2 or pcACE2. This study provides useful data to elucidate the role of
raccoon dog in SARS outbreaks.
INTRODUCTION
Severe acute respiratory syndrome (SARS), a disease that
first occurred in November 2002 in Guangdong Province,
China, has caused over 8000 infections worldwide with a
fatality rate up to 10% within several months (WHO,
2004). A novel coronavirus, SARS-CoV, was identified as
the aetiological agent of the disease (Drosten et al., 2003;
Fouchier et al., 2003; Ksiazek et al., 2003; Peiris et al., 2003)
and phylogenetic analysis indicated that the virus was
different from previously known coronaviruses (Marra
et al., 2003; Rota et al., 2003).
Although the identification of the aetiological agent and
molecular studies on SARS-CoV proceeded rather rapidly,
the puzzle of the origin of the disease was still not fully
resolved. There appears to be a reservoir for SARS-CoV in
wild animals, because a high proportion of early SARS
patients were food handlers with likely animal contact in
Guangdong Province (Normile & Enserink, 2003). SARS-
CoV-like viruses with extremely high sequence identity to
SARS-CoV were isolated from masked palm civets
(Paguma larvata) and a raccoon dog (Nyctereutes procyo-
noides) from a live-animal market, suggesting that these
animals played important roles in the transmission of
SARS-CoV (Guan et al., 2003). Later on, several investi-
gations confirmed that masked palm civet in the market
was a critical intermediate host, but not a natural reservoir,
for SARS-CoV (Tu et al., 2004; Kan et al., 2005; Poon et al.,
2005; Song et al., 2005; Wang et al., 2005). Horseshoe bat
was later on identified as a natural reservoir for SARS-
CoV-like viruses (Lau et al., 2005; W. Li et al., 2005b);
however, the variation of the spike (S) protein of bat SARS-
CoV-like virus indicated that the viruses discovered so far
from bats cannot infect human cells directly (Ren et al.,
The GenBank/EMBL/DDBJ accession number for the full-length
sequence of the raccoon dog ACE2 gene determined in this study is
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2008). Therefore, there are still unknown elements in the
transmission cycle of SARS-CoV.
SARS-CoV uses a cell-surface zinc peptidase, angiotensin-
converting enzyme 2 (ACE2), as its receptor (Li et al.,
2003). ACE2 genes from several species have been
sequenced and it has been shown that the efficiencies of
infection in humans, mice and rats correlate with the
ability of the ACE2 from each species to support virus
replication (Li et al., 2004; Subbarao et al., 2004;
Wentworth et al., 2004).
Although SARS-CoV-like viruses were detected from
raccoon dogs in both 2003 and 2004 (Guan et al., 2003;
Kan et al., 2005), very limited research was focused on the
role of raccoon dogs in the SARS epidemic. In this study,
ACE2 was extracted from raccoon dog, and a HeLa cell line
stably expressing the raccoon dog ACE2 (rdACE2) protein
was established. By using pseudotyped SARS-CoV, we
determined whether rdACE2 can be used as the receptor
for SARS-CoV and its efficiency in comparison to ACE2
proteins from human and masked palm civet. We hope
that the results further our understanding of the role of the
raccoon dog in the SARS epidemic, and provide useful data
for prevention of the possible re-emergence of SARS.
METHODS
RNA extraction, DNA sequencing and analysis. RNA was
extracted from a mixture of the heart, liver, spleen and lung from a
raccoon dog (obtained in October 2006 from a live-animal retail
market in Hebei Province, China) with TRIzol (Invitrogen),
according to the manufacturer’s instructions. RNA was dissolved in
20 ml diethyl pyrocarbonate-treated water and stored at 280 uC.
RNA was reverse-transcribed to cDNA by using a combined gene-
specific priming, random-priming and oligo-dT-priming strategy by
using SuperScript II reverse transcriptase (Invitrogen). Five overlap-
ping DNA fragments covering the full-length ACE2 gene were
produced by PCR using the following primers, which were designed
based on the most conserved regions of a sequence alignment of
ACE2 genes from ten SARS-associated animals: ACE2F1, 59-
CCGGATCCATGTCAGGCTCTTCCTGGCTC-39; ACE2F2, 59-CC-
GGATCCCTCCTTCAACTTCTTTGTCAC-39; ACE2F3, 59-GCGGG-
ATCCCAAGAACCAACGATTGAACAC-39; ACE2F4, 59-GCGGGAT-
CCGGTAGATTTTGGACAAATCTGT-39; ACE2F5, 59-GCGGGAT-
CCTGGTGGGAGATGAAGCGA-39; ACE2R1, 59-GGCTCGAGCTA-
AAATGAAGTCTGAGCATC-39; ACE2R2, 59-GGCTCGAGACAAG-
CTTTTCCAGTACTGTA-39; ACE2R3, 59-GCGCTCGAGGTAACA-
TCTATGTTTGGTTTCTG-39; ACE2R4, 59-GCGCTCGAGATGTTT-
CATCATGGGGCACAG-39; ACE2R5, 59-GCGCTCGAGACATCCT-
GATGGCCTCTTC-39. The underlined sequences are restriction-
enzyme digestion sites.
The PCR products were purified and cloned into the pGEM-T Easy
vector (Promega) separately for sequencing, which was performed on
a CEQ8000 sequencer (Beckman Coulter) with M13 forward and
reverse primers (M13F, 59-CGCCAGGGTTTTCCCAGTCACGAC-39;
M13R, 59-TCACACAGGAAACAGCTATGAC-39). Then, all five PCR
fragments were spliced by the overlap-extension PCR method
(Horton et al., 1989) to obtain the full-length rdACE2 gene, which
was sequenced again for absolute accuracy of the rdACE2 sequence.
Alignment analyses of nucleic acid and amino acid sequences were
performed by using the CLUSTAL W (version 1.83) software
(Thompson et al., 1994). Phylogenetic trees were constructed based
on amino acid sequences by using the neighbour-joining algorithm in
the MEGA3.1 software package (Kumar et al., 2004).
Generation of cell lines stably expressing ACE2 proteins. The
HeLa-huACE2 and HeLa-pcACE2 cell lines, which stably express
ACE2 from human and palm civet, respectively, were constructed
previously (Qu et al., 2005). Generation of a cell line stably
expressing rdACE2 was established by using a Moloney murine
leukemia virus-based pseudotyped system termed pVPack
(Stratagene). Briefly, the rdACE2 gene was cloned into retroviral
vector pFB-Neo to generate pFB-rdACE2, then HEK293T cells were
cotransfected by the calcium phosphate method with pFB-rdACE2, a
vesicular stomatitis virus protein G (VSV-G)-expressing vector
(pVPack-VSV-G) and a gag–pol-expressing vector (pVPack-GP). At
48 h post-transfection, viral supernatants were harvested, cell debris
was cleared by centrifugation and HeLa cells were then transduced.
The medium was replaced 8 h post-transduction and the cells were
selected in growth medium containing 800 mg G418 ml21
(Amresco). A cell line stably expressing rdACE2 was selected by
limiting dilution for four passages in 1 month.
Rabbit polyclonal antibodies against huACE2, pcACE2 and rdACE2
were generated with recombinant full-length ACE2 proteins expressed
in the pProEXHT (Gibco-BRL) expression system. Purified proteins
(200 mg) were used to immunize rabbits. After 3 weeks, the rabbits
received a booster with the same amount of the antigens. Two weeks
later, antisera were collected and stored at 280 uC.
Stable expression of human, palm civet and raccoon dog ACE2 in
HeLa cells was detected by using rabbit antibodies against huACE2,
pcACE2 and rdACE2, respectively. Also, cross-reactions between
ACE2 proteins and anti-ACE2 antibodies were tested. Cell lysates
were separated by SDS-PAGE and then transferred to nitrocellulose
membranes (Millipore). The membranes were incubated separately
with rabbit anti-huACE2, anti-pcACE2 and anti-rdACE2 (1 : 1000)
and bound antibodies were detected by using alkaline phosphatase-
conjugated goat anti-rabbit IgG (1 : 2000) (SABC). The signal was
detected with a BCIP–nitro blue tetrazolium kit (SABC).
Fluorescence-activated cell sorting (FACS) analysis of ACE2-
expressing cells. Firstly, rabbit anti-huACE2 antibody was
purified by protein A–Sepharose chromatography (Calbiochem)
and conjugated with fluorescein isothiocyanate (FITC; AnaSpec) in
DMSO (Sigma). Secondly, ACE2-expressing and control HeLa cells
were cultured on coverslips in 24-well plates (Corning). The
following day, the cells were washed with cold PBS and harvested
with PBS containing 5 mM EDTA for 10 min at 4 uC and spun at
1000 g for 5 min, followed by overnight incubation with FITC-
conjugated rabbit anti-huACE2 antibody (at a 1 : 100 dilution in
PBS with 3% goat serum) at 4 uC. The next day, after two washes
with cold PBS, the cells were fixed by resuspending them in 2%
paraformaldehyde and incubated at room temperature for 15 min.
Finally, the cells were washed twice and resuspended in 500 ml
cold PBS, and flow-cytometry analysis (Epics Altra II; Beckman
Coulter) was performed.
ACE2 activity assay. The cell-membrane fraction was prepared by
using a ProteoPrep Membrane Extraction kit (Sigma). The protein
content of the membrane was determined with a BCA Protein Assay
kit (Biyotime), using bovine serum albumin as a standard. The
activity of the ACE2 assay was determined as described by Douglas
et al. (2004) using the ACE2-specific quenched fluorescent substrate
QFS (7-methoxycoumarin-4-yl)-acetyl-Ala-Pro-Lys(2,4-dinitrophe-
nyl) (Auspep). Assays were performed in black 96-well plates with
50 mM QFS per reaction and incubated at 37 uC for 1 h. Liberated
fluorescence (in relative fluorescence units) was measured at
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320–420 nm. To demonstrate specific inhibition, ACE2 activity was
also determined in the presence of 0.1 mM EDTA.
Construction of full-length S genes with distinct receptor-
binding domain (RBD) sequences. Four full-length SARS-CoV S
genes with a codon-optimized S backbone from human SARS-CoV,
but with distinct RBD sequences from strain BJ01 (human), palm
civets in Guangdong Province (pcGD) and in Hubei Province (pcES)
and a raccoon dog in Shenzhen from 2003 (rd03SZ), were generated
in a previous study (Liu et al., 2007). For the current study, the RBD
sequence of the S gene from a raccoon dog in Guangzhou from 2004
(rd04GZ) was constructed by site-directed mutagenesis. Primers were
designed based on the sequences of S genes A030 (GenBank accession
no. AY687357) and A031 (accession no. AY687358), which were
detected in market raccoon dogs in 2004 and have 100% sequence
identity. All five S genes were cloned individually into the pcDNA3.1
vector (Invitrogen). Amino acid differences in the RBDs of the above
S glycoproteins are listed in Table 1.
Virus entry assay with HIV-luc/SARS-pseudotyped virus. The
pseudoviruses were generated by cotransfecting 56107 HEK293T
cells in 100 mm cell-culture dishes (Corning) with a human
immunodeficiency virus type 1 (HIV-1) pNL4.3Luc+Env2Vpr2
backbone (30 mg) and one of the above-mentioned, full-length S
gene-expression plasmids (30 mg) by using Lipofectamine 2000
(Invitrogen). Viral supernatants were harvested 48 h post-transfec-
tion, clarified from cell debris by centrifugation at 3000 g for
10 min and filtered through a 0.45 mm pore-size filter (Millipore).
Pseudoviruses in the cell supernatants were purified by ultracen-
trifugation through a 20% sucrose cushion at 55 000 g for 90 min
using a Ty90 rotor (Beckman). The pelleted pseudoviruses were
dissolved in 60 ml PBS. To evaluate the incorporation of S proteins
and HIV P24 into the pseudotyped viruses, 10 ml of each purified
virus was subjected to SDS-PAGE and Western blotting with each
antibody. The supernatant was assayed for P24 by using an HIV-1
P24 antigen ELISA kit (provided by the mAb laboratory of the
Wuhan Institute of Virology, Chinese Academy of Sciences). HeLa
cells (16106 cells) stably expressing similar amounts of huACE2,
rdACE2 or pcACE2 were seeded into 24-well plates and transduced
24 h later with equivalent amounts of the respective pseudovirus.
The efficiency of virus entry was monitored by a luciferase
reporter gene in the pseudovirus (Promega) by using a Turner
Designs TD-20/20 luminometer. Each transduction experiment
was conducted in triplicate and all experiments were repeated four
times.
Statistical analysis. Statistical analysis of the entry efficiencies was
performed by SPSS 11.5 software and the DUNCAN and LSD methods
were used for detection in one-way ANOVA means.
RESULTS
Sequence analysis of the rdACE2 protein
The full-length sequence of raccoon dog ACE2 was
obtained by cloning and sequencing as described in
Methods. The coding region was deposited in GenBank
under accession number EU024940.
The rdACE2 gene encodes an 804 aa protein, which is
identical in size to the ACE2 protein of dog, but 1 aa
shorter than those of human and palm civet. Sequence
alignment indicated that the rdACE2 molecule has an
amino acid sequence identity of 99.3% to dog ACE2,
90.7% to cat ACE2, 90.5% to raccoon ACE2, 89.2% to
pcACE2, 83.9% to huACE2, 81.6% to mouse ACE2,
81.4% to rat ACE2, 80.5% to ferret ACE2 and 80.4% to
bat ACE2. ACE2 of raccoon dog was almost identical to
dog ACE2, with only six amino acid differences at residues
26, 52, 59, 326, 340 and 353. A sequence alignment and a
phylogenetic tree are shown in Fig. 1. There appear to be
four groups of ACE2 proteins based on phylogenetic
analysis: group I contains the ACE2 proteins of raccoon
dog, dog, ferret, raccoon, masked palm civet and cat, group
II contains those of human and VeroE6 cells, group III
contains those of mouse and rat and group IV contains
that of bat (Fig. 1b).
It was reported that there are 18 residues of ACE2 that
make direct contact with the SARS-CoV S protein (F. Li et
al., 2005) (Table 2, columns marked *). For these 18
residues, there are six changes in rdACE2 compared with
the cognate human protein: Q24L (Q in huACE2 and L in
rdACE2 at residue 24), H34Y, D38E, M82T, N90D and
K353R, and four changes compared with pcACE2 (T31K,
Q37E, V45L and K353R). Three regions within the S–ACE2
complex domain (W. Li et al., 2005a) differed significantly
between rdACE2, huACE2 and pcACE2 (Table 2): the
region of a-helix 1 (residues 30–41) varied at four residues
from huACE2 and two from pcACE2; the loop initiating
ACE2 a-helix 3 (residues 90–93) differed by two residues
from huACE2 and three from pcACE2; and a loop and b5
(residues 353–357) had only one variation in rdACE2, and
this variation (K353R in rdACE2) has never been found in
any other species (although there is a histidine in the
mouse and rat ACE2 proteins). This position was reported
to be one of the most critical residues in ACE2 for binding
to the SARS-CoV S protein (Li, 2008; F. Li et al., 2005; W.
Li et al., 2005a).
Generation of a HeLa cell line stably expressing
the rdACE2 protein
A HeLa cell line that stably expresses the rdACE2 protein
was established as described in Methods. Rabbit polyclonal
antibodies against huACE2, pcACE2 and rdACE2 were
generated by using recombinant prokaryotic-expressed
full-length ACE2 proteins. Western blot analysis showed
that rdACE2 was expressed efficiently in HeLa cells and was
Table 1. Amino acid differences in the RBDs of S glyco-
proteins used in this study
Virus Residue at position
344 360 462 472 479 480 487
Human SARS-CoV K F P L N D T
pcGD R S P P N G S
pcES R F P P R G S
rd03SZ R S P L K D S
rd04GZ R S S P R G S
ACE2 from raccoon dog as a receptor for SARS-CoV
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Fig. 1. Sequence analysis of rdACE2. (a) Multiple amino acid sequence alignment of ACE2 from different mammals. The GenBank accession numbers for
the ACE2 proteins are as follows: raccoon dog, EU024940; dog, XM_537964; ferret, AB208708; raccoon, AB211998; masked palm civet, AY881174;
bat, AB299376; human, AB193260.1; African green monkey, AY996037; cat, AB211997; mouse, AK141604; rat, AY881244. (b) A phylogenetic tree
was constructed based on amino acid sequences of different ACE2 proteins using the neighbour-joining algorithm in the MEGA3.1 software package, with
bootstrap values (%) determined by 500 replicates.
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recognized by anti-rdACE2 antibody (Fig. 2). Moreover,
cross-reactions with the three antibodies indicated that the
cell lines expressed comparable amounts of the different
proteins and that any of the antisera can be used effectively
to detect the receptors from the three species (Fig. 2).
To detect the expression of ACE2 at the cell surface, FACS
analysis was performed. The result is shown in Fig. 3. Cells
stably expressing huACE2, pcACE2 or rdACE2 exhibited
comparable positive-cell ratios (P.0.05) when using FITC-
conjugated rabbit anti-huACE2 antibody for detection,
which were significantly higher than those for the control
HeLa cells.
ACE2 proteins were assessed further by an enzyme-activity
assay using an ACE2-specific peptide substrate, QFS. As
shown in Fig. 4, membrane fractions prepared from the
three cell lines displayed substantially higher protease
activities toward QFS than the control HeLa cells (Fig. 4a).
Furthermore, the protease activity was largely abolished in
the presence of 0.1 mM EDTA, a known inhibitor of ACE2
proteases (Fig. 4b).
Analysis of S protein expression and pseudovirus
packaging
The expression of different S proteins and their correct
incorporation into pseudoviruses were monitored by
Western blotting of purified virions using both S- and
P24-specific mAbs. Pseudoviruses were purified by ultra-
centrifugation through a 20% sucrose cushion and
subjected to SDS-PAGE for Western blotting with each
antibody. The results showed that all genes encoding an S
protein were expressed efficiently and incorporated into
the respective pseudoviruses at comparable levels (Fig. 5).
Comparison of the entry efficiencies of different
pseudoviruses into different ACE2-expressing
cells
As shown in Fig. 6, when HIV/human-S pseudovirus was
used to infect HeLa-huACE2, HeLa-pcACE2 and HeLa-
rdACE2 cells, higher levels of luciferase activity (.26105
relative light units) were detected in the cell lysates of
HeLa-rdACE2 than in HeLa-huACE2 and HeLa-pcACE2
cell lysates. If the entry efficiency of HIV/human-S
pseudovirus into HeLa-rdACE2 cells was defined as
100%, then those of HIV/human-S pseudovirus into
HeLa-huACE2 and HeLa-pcACE2 cells were 65.6 and
53.0%, respectively. Statistical analysis by SPSS software
indicated that the entry efficiencies were significantly
different from each other when HIV/human-S pseudovirus
infected the three ACE2-expressing cell lines (P,0.01). In
contrast, when other animal-derived pseudoviruses were
used to infect HeLa-rdACE2 cells, much lower luciferase
activities were observed, especially when raccoon dog-
derived pseudoviruses (HIV/rd03SZ-S and HIV/rd04GZ-S)
were used. In the latter case, approximately 103 relative
light units were detected, and the infection abilities wereT
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,3% (1.5 and 2.5%, respectively) of that of HIV/human-S
pseudovirus infected into HeLa-rdACE2 cells. Statistical
analyses showed that, when HeLa-huACE2 and HeLa-
rdACE2 cells were infected by HIV/rd03SZ-S and HIV/
rd04GZ-S, the difference in entry efficiencies is not
significant (P.0.05). However, it seems that HeLa-
pcACE2 is relatively more acceptable to both HIV/
rd03SZ-S and HIV/rd04GZ-S than HeLa-huACE2 and
HeLa-rdACE2 (P,0.01). Meanwhile, we also observed that
huACE2 is most sensitive to human-derived SARS-CoV,
and pcACE2 is most sensitive to masked palm civet-derived
SARS-CoV-like viruses, consistent with previous reports
(W. Li et al., 2005a; Liu et al., 2007).
DISCUSSION
In this study, ACE2 from raccoon dog was cloned,
sequenced and compared with ACE2s from human and
palm civet for entry efficiency of SARS-CoV and SARS-
CoV-like viruses.
Our results showed that rdACE2 could mediate human
SARS-CoV entry more efficiently than huACE2 and
pcACE2. Sequence analysis revealed that there are six
changes in rdACE2 compared with huACE2, and four
changes compared with pcACE2, within the 18 residues of
ACE2 known to make direct contact with the SARS-CoV S
protein (F. Li et al., 2005) (Table 2). These changes may
contribute to the increased entry efficiency of human
SARS-CoV. The most noticeable residue was 353, which
was an arginine in rdACE2 that has never been found in
any other species (although a histidine has been reported at
this position in mouse and rat ACE2 proteins). This
position was reported to be one of the most critical
residues in ACE2 for binding the SARS-CoV S protein
(F. Li et al., 2005; W. Li et al., 2005a; Li, 2008). W. Li et al.
(2005a) made a series of huACE2 variants in which one or
a few solvent-exposed residues were altered to their rat
ACE2 counterparts. Alteration of lysine 353 to a histidine
residue, as present on the rat receptor, dramatically
inhibited S protein-mediated entry. In contrast, introduc-
tion of human lysine 353 into rat ACE2 converted it to an
efficient receptor for SARS-CoV. These data suggested that
residue 353 in ACE2 plays a critical role in S-protein
binding and subsequent cell entry. Structural studies of
huACE2 complexed with the human SARS-CoV S-protein
RBD suggested that the side chain of ACE2 Lys353 folds
back and is embedded in a hydrophobic tunnel surrounded
by Tyr484, Tyr491 and Thr487 of the RBD and Tyr41 of
ACE2. At the opening of the tunnel is Asp38 of ACE2,
which neutralizes the charge of Lys353 and stabilizes the
interface. The stability and intensity of this complex appear
to be critical for S–ACE2 interaction activity (F. Li et al.,
2005; Li, 2008). On rdACE2, Arg353 is present instead of
Lys353 (which is present in the human and palm civet
ACE2 proteins). Both arginine and lysine are positive-
charged amino acids and arginine has a longer side chain,
which may embed more deeply and more stably into the
hydrophobic tunnel surrounded by residues 484, 491 and
487 of the RBD and residue 41 of ACE2. Interestingly,
Glu38 occurs in rdACE2 instead of Asp38 in huACE2, both
of which are negative-charged amino acids that can
neutralize the positive charge of residue 353 and stabilize
the interface. It is plausible that, in comparison to the
human and palm civet ACE2 proteins, residue 353 of
rdACE2 interacts more stably with surrounding residues
and, with the interaction of Glu38, results in a more
efficient SARS-CoV S-binding activity.
It is then interesting to know why, when pseudoviruses
derived from palm civets and raccoon dogs were used, the
binding efficiencies with rdACE2 were not higher than
Fig. 3. FACS analysis of ACE2-expressing HeLa cell lines. HeLa
cells with no exogenous ACE2 gene were used as negative
controls. HeLa cells expressing huACE2, pcACE2 and rdACE2
were detected by FACS using FITC-conjugated rabbit anti-
huACE2 antibody. Error bars indicate SD.
Fig. 2. Detection of human, palm civet and raccoon dog ACE2 in
stably transformed cell lines by anti-huACE2, -pcACE2 and
-rdACE2 antibodies. Anti-b-actin antibody was used to detect
the input amount of each cell line. Lanes: 1, HeLa; 2, HeLa-
huACE2; 3, HeLa-pcACE2; 4, HeLa-rdACE2.
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those of huACE2 and pcACE2. Li (2008) reported that the
side chain of residue 38 of ACE2 by itself was not sufficient
to form a strong and stable salt-bridge bond with residue
353, which appears to require support from the c-methyl
group of RBD Thr487. The c-methyl group of the side
chain of RBD Thr487 is important for placing the side
chain of ACE2 residue 353 in position to form a salt bridge
with ACE2 residue 38. Without this methyl group, residues
at position 353 would not be able to form a strong and
stable salt bridge with residue 38, leaving a free positive
charge in a hydrophobic tunnel and destabilizing the
interface (Li, 2008). However, RBD Thr487 in the human S
protein is replaced by Ser487 in the palm civet and raccoon
dog S proteins, and there is no c-methyl group in Ser487. It
has also been reported that Ser487 on RBD dramatically
reduces the affinity for huACE2 by over 20-fold (W. Li et
al., 2005a; Qu et al., 2005). This may explain why
pseudoviruses derived from SARS-CoV-like viruses of
palm civets and raccoon dogs had lower entry efficiencies
into HeLa-rdACE2 cells than human SARS-CoV.
Another phenomenon that we observed in this study was
that HeLa-pcACE2 cells are relatively more sensitive to
pseudoviruses derived from SARS-CoV-like viruses of
palm civets and raccoon dogs than HeLa-huACE2 and
HeLa-rdACE2 cells, consistent with previous reports that
pcACE2 was comparatively more susceptible to different S
proteins than huACE2 (W. Li et al., 2005a; Li et al., 2006;
Li, 2008). Meanwhile, we also observed that huACE2 is
most sensitive to human-derived SARS-CoV, and palm
civet-derived SARS-CoV-like viruses are most infectious to
pcACE2, which has been reported previously (W. Li et al.,
2005a; Liu et al., 2007).
In our study, the entry efficiency of pesudoviruses derived
from raccoon dog S proteins was poor in the cell lines
expressing huACE2, pcACE2 or rdACE2. This may reflect
that the SARS-CoV-like viruses from raccoon dogs could
not use these ACE2 proteins efficiently for cell entry.
Amino acid sequence alignments of S-protein RBDs
showed that rd04GZ has two single-nucleotide polymorph-
isms (SNPs) compared with pcGD or pcES: residues 462,
479 and 360. However, their infectivities are distinct, which
Fig. 4. Determination of ACE2 activity.
Protease activities from different ACE2-
expressing cell-membrane fractions were
determined by using the ACE2-specific sub-
strate QFS (see Methods). Liberated fluor-
escence [in relative fluorescence units (RFU)]
determined at 320–420 nm in the absence (a)
and presence (b) of EDTA is shown. HeLa
cells with no exogenous ACE2 gene and TBS
buffer were used as negative controls. Error
bars indicate SD.
Fig. 5. Detection of S protein incorporated into pseudoviruses.
Western blotting of purified virions was performed with S-specific
and P24-specific mAbs. Lanes: 1, HIV/human-S; 2, HIV/pcGD S;
3, HIV/pcES S; 4, HIV/rd03SZ S; 5, HIV/rd04GZ S; 6, HIV.
Fig. 6. Comparison of the entry efficiencies of different pseudo-
viruses into different ACE2-expressing cells. Five pseudoviruses
derived from human, palm civet and raccoon dog are shown on the
x-axis; detected luciferase activity/entry efficiency is shown on the
y-axis. The entry efficiency of human-derived pseudovirus into
HeLa-rdACE2 cells was regarded as 100%. Empty, shaded and
filled bars represent the entry efficiencies of different pseudo-
viruses into HeLa-huACE2, HeLa-pcACE2 and HeLa-rdACE2
cells, respectively.
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means these three residues may have certain impacts on S–
ACE2 interaction. Meanwhile, when the two raccoon dog-
derived viruses were compared, there are four SNPs in the
RBD: residues 462, 472, 479 and 480. Although their
infectivities are very similar, it is possible that, when these
four SNPs exist together, the influence on S–ACE2
interaction is limited. However, when another two
mutations at residues 344 and 487 are added to the above
four SNPs, virus entry efficiencies are inhibited dramat-
ically, despite the hypothesis of Qu et al. (2005) and Li
(2008) that the inhibition was mainly caused by mutations
of residues 479 and 487. However, we need to mention
that, apart from the RBD region, other parts of the S genes
from the raccoon dog viruses also contain mutations that
may have impacts on entry efficiency. Therefore, a more
desirable conclusion can only be addressed when full-
length S genes are used. It is also possible that another
unknown molecule in the raccoon dog may serve as a
receptor or co-receptor for raccoon dog SARS-CoV-like
viruses, which will require further studies for verification.
Notably, amino acid sequence analysis indicated that
rdACE2 has an identity of 99.3% to dog ACE2. Whether
dogs are also susceptible to SARS-CoV infection is worthy
of study. If so, dogs may be a good candidate for an animal
model for SARS-CoV.
In summary, our results suggest that rdACE2 is a more
efficient receptor for human SARS-CoV, but not for SARS-
CoV-like viruses from palm civets and raccoon dogs, than
the human and palm civet ACE2 proteins. The data indicate
that raccoon dog may serve as a critical intermediate host for
SARS-CoV and may play an important role in SARS
outbreaks. The highly efficient interaction between SARS-
CoV and rdACE2 may impose an important impact on the
evolution of human SARS-CoV, whilst other host and
environmental factors may also contribute to the emergence
and spread of SARS-CoV. Therefore, further studies are
required to understand completely the initiation of SARS
outbreaks and animal reservoirs.
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